Related Experiment Video
Updated: Jul 23, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
COVID-19-associated MRSA infective endocarditis and mitral valve perforation: a case report
Anwar Khedr1, Esraa Mamdouh Hassan2, Hussam Al Hennawi3
1BronxCare Health System, Bronx, NY, USA.
Insights
This case report details a patient with Coronavirus disease 2019 (COVID-19) who developed infective endocarditis (IE) due to methicillin-resistant Staphylococcus aureus. Prompt diagnosis via transesophageal echocardiography is crucial for COVID-19 patients with suspected IE.
Area of Science:
- Infectious Diseases
- Cardiology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic with significant health impacts.
- Comorbidities can complicate COVID-19 diagnosis and management.
- Understanding COVID-19's interaction with other conditions is essential.
Purpose of the Study:
- To report a case of infective endocarditis (IE) in a patient with COVID-19.
- To highlight the diagnostic utility of transesophageal echocardiography in such cases.
- To explore the potential association between COVID-19 and IE.
Main Methods:
- Case report presentation of a COVID-19 patient.
- Detailed clinical history including risk factors for bacteremia (diabetes mellitus, steroid use).
- Diagnostic confirmation using transesophageal echocardiography.
Main Results:
- The patient developed infective endocarditis and mitral valve perforation caused by methicillin-resistant Staphylococcus aureus.
- Typical IE risk factors like intravenous drug use were absent.
- Transesophageal echocardiography was key in diagnosing IE.
Conclusions:
- COVID-19 may be associated with an increased risk of developing infective endocarditis.
- Transesophageal echocardiography is vital for diagnosing IE in COVID-19 patients with high clinical suspicion.
- Further research is needed to clarify the relationship between COVID-19 and IE.
Background:
Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic, leading to significant morbidity and mortality. The interplay between COVID-19 and other medical conditions can complicate diagnosis and management, necessitating further exploration.
Case Presentation:
This case report presents a patient with COVID-19 who developed infective endocarditis (IE) and mitral valve perforation caused by methicillin-resistant Staphylococcus aureus on a native mitral valve. Notably, the patient did not exhibit typical IE risk factors, such as intravenous drug use. However, he did possess risk factors for bacteremia, including a history of diabetes mellitus and recent steroid use due to the COVID-19 infection. The diagnosis of IE was crucially facilitated by transesophageal echocardiography.
Conclusions:
This case highlights the potential association between COVID-19 and the development of infective endocarditis. Prompt evaluation using transesophageal echocardiography is vital when there is a high suspicion of IE in COVID-19 patients. Further research is required to elucidate the precise relationship between COVID-19 and IE.
Related Concept Videos
Endocarditis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Regurgitation I: Introduction

